Opening will enable pharmaceutical company to better provide UK market with direct distribution and client-facing team. UK third direct-selling country for Provepharm, after France and the United States, expanding commercial presence in medical dye and antidote markets
Since 2022, Provepharm reached an important milestone in its CSR strategy. In this "2023 CSR Impact, new edition " the essential elements of our approach have been grouped together.
Provepharm, an international, private and sustainable pharmaceutical company specialized in revitalizing molecules and Pharm-D, a healthcare and pharmaceutical company based in Malaysia with a strong foothold in Singapore, announce today their partnership to launch Proveblue® 5 mg/ml solution for injection in Malaysia.
We are pleased to present our latest Corporate film.
On Tuesday July 18, 2023, the 140 Provepharm employees, some of whom came from the USA and the UK, celebrated the quarter century of the pharmaceutical laboratory in an emblematic place in Marseille, Casa Delauze.
The 18th annual event of ETPN & the 5th ENM conference merged into a unique event: #NME23
At Provepharm Life Solutions, we innovate to realize each molecule's full potential, to provide treatments that help improve patients' lives.